Live Accenture Plc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow 23andMe Holding Co.

Get SEC filing alerts via email and in your feed for 23andMe Holding Co.

ME MEHCQ

23andMe Holding Co.

About 23andMe Holding Co.

23andMe Holding Co. is a genetic testing and research company that empowers individuals to access and understand their genetic information. Its key offerings include direct-to-consumer genetic tests, health reports, and telehealth services through Lemonaid Health. With a focus on personalized healthcare, 23andMe targets consumers seeking insights into their health risks and ancestry. The company is navigating significant restructuring and bankruptcy proceedings while aiming to innovate in genetic research and healthcare delivery.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from 23andMe Holding Co.

1
1
23andMe Holding Co. 23andMe Reports 37% Revenue Decline and $23.8 Million Net Loss in Latest Quarter

Via official filing (AI summary) | 11 months ago | 0 comments

2
1
23andMe Holding Co. 23andMe Reports $235.2M Net Loss Amid Chapter 11 Bankruptcy Proceedings

Via official filing (AI summary) | about 1 year ago | 0 comments

3
1
23andMe Holding Co. 23andMe Reports 35% Revenue Growth to $60.3 Million in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments

4
1
23andMe Holding Co. 23andMe Reports 12% Decline in Revenue, Net Loss, and Doubts About Going Concern

Via official filing (AI summary) | over 1 year ago | 0 comments